214 related articles for article (PubMed ID: 26322633)
1. Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections.
Romero-Saavedra F; Laverde D; Budin-Verneuil A; Muller C; Bernay B; Benachour A; Hartke A; Huebner J
PLoS One; 2015; 10(8):e0136625. PubMed ID: 26322633
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage.
Romero-Saavedra F; Laverde D; Kalfopoulou E; Martini C; Torelli R; Martinez-Matamoros D; Sanguinetti M; Huebner J
J Infect Dis; 2019 Oct; 220(10):1589-1598. PubMed ID: 31289829
[TBL] [Abstract][Full Text] [Related]
3. Identification of peptidoglycan-associated proteins as vaccine candidates for enterococcal infections.
Romero-Saavedra F; Laverde D; Wobser D; Michaux C; Budin-Verneuil A; Bernay B; Benachour A; Hartke A; Huebner J
PLoS One; 2014; 9(11):e111880. PubMed ID: 25369230
[TBL] [Abstract][Full Text] [Related]
4. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections.
Kropec A; Sava IG; Vonend C; Sakinc T; Grohmann E; Huebner J
Microbiology (Reading); 2011 Dec; 157(Pt 12):3429-3434. PubMed ID: 21903755
[TBL] [Abstract][Full Text] [Related]
5. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection.
Sava IG; Heikens E; Kropec A; Theilacker C; Willems R; Huebner J
J Med Microbiol; 2010 Sep; 59(Pt 9):1001-1004. PubMed ID: 20522627
[TBL] [Abstract][Full Text] [Related]
6. A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.
Kodali S; Vinogradov E; Lin F; Khoury N; Hao L; Pavliak V; Jones CH; Laverde D; Huebner J; Jansen KU; Anderson AS; Donald RG
J Biol Chem; 2015 Aug; 290(32):19512-26. PubMed ID: 26109072
[TBL] [Abstract][Full Text] [Related]
7. Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci.
Kalfopoulou E; Laverde D; Miklic K; Romero-Saavedra F; Malic S; Carboni F; Adamo R; Lenac Rovis T; Jonjic S; Huebner J
Infect Immun; 2019 Sep; 87(9):. PubMed ID: 31285252
[TBL] [Abstract][Full Text] [Related]
8. Immunization with the basic membrane protein (BMP) family ABC transporter elicits protection against Enterococcus faecium in a murine infection model.
Yousief SW; Bahey-El-Din M; Zaghloul TI
Microbes Infect; 2020 Apr; 22(3):127-136. PubMed ID: 31585177
[TBL] [Abstract][Full Text] [Related]
9. Molecular Cloning and Immunogenicity Evaluation of PpiC, GelE, and VS87_01105 Proteins of Enterococcus faecalis as Vaccine Candidates.
Kazemian H; Pourmand MR; Siadat SD; Mahdavi M; Yazdi MH; Avakh Majelan P; Afshar D; Yaseri M; Davari M; Ibrahim Getso M
Iran Biomed J; 2019 Sep; 23(5):344-53. PubMed ID: 31103023
[TBL] [Abstract][Full Text] [Related]
10. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.
Huebner J; Wang Y; Krueger WA; Madoff LC; Martirosian G; Boisot S; Goldmann DA; Kasper DL; Tzianabos AO; Pier GB
Infect Immun; 1999 Mar; 67(3):1213-9. PubMed ID: 10024563
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.
Huebner J; Quaas A; Krueger WA; Goldmann DA; Pier GB
Infect Immun; 2000 Aug; 68(8):4631-6. PubMed ID: 10899866
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of bacterial polysaccharides in drug-resistant enterococci.
Ali L; Blum HE; Sakιnç T
Glycoconj J; 2019 Oct; 36(5):429-438. PubMed ID: 31230165
[TBL] [Abstract][Full Text] [Related]
13. Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited.
Theilacker C; Kaczyński Z; Kropec A; Sava I; Ye L; Bychowska A; Holst O; Huebner J
PLoS One; 2011 Mar; 6(3):e17839. PubMed ID: 21437253
[TBL] [Abstract][Full Text] [Related]
14. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
[TBL] [Abstract][Full Text] [Related]
15. Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy.
Burnie J; Carter T; Rigg G; Hodgetts S; Donohoe M; Matthews R
FEMS Immunol Med Microbiol; 2002 Jul; 33(3):179-89. PubMed ID: 12110480
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis and immunity in enterococcal infections.
Sava IG; Heikens E; Huebner J
Clin Microbiol Infect; 2010 Jun; 16(6):533-40. PubMed ID: 20569264
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the development of immunotherapy regimens against enterococcal infections.
Theilacker C; Krueger WA; Kropec A; Huebner J
Vaccine; 2004 Dec; 22 Suppl 1():S31-8. PubMed ID: 15576199
[TBL] [Abstract][Full Text] [Related]
18. The complement system facilitates clearance of Enterococcus faecium during murine peritonitis.
Leendertse M; Willems RJ; Flierman R; de Vos AF; Bonten MJ; van der Poll T
J Infect Dis; 2010 Feb; 201(4):544-52. PubMed ID: 20064073
[TBL] [Abstract][Full Text] [Related]
19. Enterococcal infections: host response, therapeutic, and prophylactic possibilities.
Koch S; Hufnagel M; Theilacker C; Huebner J
Vaccine; 2004 Feb; 22(7):822-30. PubMed ID: 15040934
[TBL] [Abstract][Full Text] [Related]
20. Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.
Laverde D; Wobser D; Romero-Saavedra F; Hogendorf W; van der Marel G; Berthold M; Kropec A; Codee J; Huebner J
PLoS One; 2014; 9(10):e110953. PubMed ID: 25333799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
